Research Paper Volume 12, Issue 14 pp 14718—14735
Demethoxycurcumin analogue DMC-BH inhibits orthotopic growth of glioma stem cells by targeting JNK/ERK signaling
Figure 6. DMC-BH reduces GSCs intracranial orthotopic growth. (D) Apoptosis of intracranial tumor analyzed by TUNEL assay. (E) Western analysis of c-caspase-3, LC3-II, p-ERK and p-JNK levels in intracranial tumors. (F) Body weight loss in DMC-BH-treated and control mice; n =10.